PHARMACOLOGICAL ACTIVATION OF THE p53 PATHWAY BY NUTLIN-3 EXERTS ANTI-TUMORAL EFFECTS IN MEDULLOBLASTOMAS

被引：0
作者：
Kuenkele, Annette [1 ]
De Preter, Katleen [2 ]
Heukamp, Lukas [3 ]
Thor, Theresa [1 ]
Pajtler, Kristian [1 ]
Hartmann, Wolfgang [3 ]
Mittelbronn, Michel [4 ]
Grotzer, Michael [5 ]
Deubzer, Hedwig [6 ]
Speleman, Frank [2 ]
Schramm, Alexander [1 ]
Eggert, Angelika [1 ]
Schulte, Johannes [1 ]
机构：
[1] Univ Childrens Hosp Essen, Essen, Germany
[2] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium
[3] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[4] Goethe Univ Frankfurt, Inst Neurol, Frankfurt, Germany
[5] Childrens Hosp Zurich, Zurich, Switzerland
[6] German Canc Res Ctr, D-6900 Heidelberg, Germany
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [41] Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment
    Tokalov, Sergey V.
    Abolmaali, Nasreddin D.
    BMC CANCER, 2010, 10
  • [42] Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status
    Wang, Dong-Mei
    Liu, Ling
    Fan, Lei
    Zou, Zhi-Jian
    Zhang, Li-Na
    Yang, Shu
    Li, Jian-Yong
    Xu, Wei
    CANCER BIOLOGY & THERAPY, 2012, 13 (14) : 1522 - 1528
  • [43] Lowering glucose increases nutlin-3 toxicity against melanomas irrespective of BRAF, NRAS or p53 mutations
    Rieber, Manuel
    Chavez-Perez, Valery
    Strasberg-Rieber, Mary
    CANCER RESEARCH, 2014, 74 (19)
  • [44] Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment
    Sergey V Tokalov
    Nasreddin D Abolmaali
    BMC Cancer, 10
  • [45] Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph plus ALL
    Guo, Yong
    Li, Yi
    Xiang, Bing
    Huang, Xiao-Ou
    Ma, Hong-Bing
    Wang, Fang-Fang
    Gong, Yu-Ping
    BIOCHEMICAL JOURNAL, 2017, 474 : 4153 - 4170
  • [46] Mdm2 antagonist Nutlin-3 induces apoptosis in p53 mutant human colon carcinoma cells
    Bhattacharya, Sujoy
    Ray, Ramesh M.
    Johnson, Leonard R.
    FASEB JOURNAL, 2009, 23
  • [47] Effect of pharmacodynamical interaction between nutlin-3a and aspirin in the activation of p53
    Awan, Muhammad Suleman
    Aslam, Maria
    Liaquat, Muwahida
    Bhatti, A., I
    Liaquat, Afrose
    JOURNAL OF THEORETICAL BIOLOGY, 2021, 522
  • [48] Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia
    Haaland, Ingvild
    Opsahl, Jill A.
    Berven, Frode S.
    Reikvam, Hakon
    Fredly, Hanne K.
    Haugse, Ragnhild
    Thiede, Bernd
    McCormack, Emmet
    Lain, Sonia
    Bruserud, Oystein
    Gjertsen, Bjorn Tore
    MOLECULAR CANCER, 2014, 13
  • [49] Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells
    Secchiero, Paola
    Zerbinati, Carlotta
    di Iasio, Maria Grazia
    Melloni, Elisabetta
    Tiribelli, Mario
    Grill, Vittorio
    Zauli, Giorgio
    CURRENT DRUG METABOLISM, 2007, 8 (04) : 395 - 403
  • [50] Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia
    Ingvild Haaland
    Jill A Opsahl
    Frode S Berven
    Håkon Reikvam
    Hanne K Fredly
    Ragnhild Haugse
    Bernd Thiede
    Emmet McCormack
    Sonia Lain
    Øystein Bruserud
    Bjørn Tore Gjertsen
    Molecular Cancer, 13
12345